How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
about
Certolizumab pegol for the treatment of Crohn's disease.Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.Patient outcomes after anti TNF-alpha drugs for Crohn's disease.A Challenging Treatment Decision for a Rare Association: Case Report of Familial Turcot Syndrome With Fistulizing Crohn's Disease.
P2860
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@en
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@nl
type
label
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@en
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@nl
prefLabel
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@en
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@nl
P2093
P2860
P921
P356
P1476
How to manage difficult Crohn's disease: optimum delivery of anti-TNFs.
@en
P2093
Brian Bressler
Darin S Krygier
Hin Hin Ko
P2860
P304
P356
10.1586/EGH.09.25
P577
2009-08-01T00:00:00Z